Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | E3 ubiquitin-protein ligase Mdm2 | ||
Ligand | BDBM135300 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | FRET Assay | ||
IC50 | 1±n/a nM | ||
Citation | Christopher, MP; Fradera Llinas, FX; Machacek, M; Martinez, M; Reutershan, MH; Shizuka, M; Sun, B; Thompson, CF; Trotter, BW; Voss, ME; Altman, MD; Bogen, SL; Doll, RJ Substituted imidazopyridines as HDM2 inhibitors US Patent US8846657 Publication Date 9/30/2014 | ||
More Info.: | Get all data from this article, Assay Method | ||
E3 ubiquitin-protein ligase Mdm2 | |||
Name: | E3 ubiquitin-protein ligase Mdm2 | ||
Synonyms: | Double minute 2 protein | Double minute 2 protein (HDM2) | E3 ubiquitin-protein ligase Mdm2 (p53-binding protein Mdm2) | Hdm2 | Human Double Minute 2 (HDM2) | MDM2 | MDM2-MDMX | MDM2_HUMAN | p53-Binding Protein MDM2 | p53-binding protein | ||
Type: | Oncoprotein | ||
Mol. Mass.: | 55196.54 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q00987 | ||
Residue: | 491 | ||
Sequence: |
| ||
BDBM135300 | |||
n/a | |||
Name | BDBM135300 | ||
Synonyms: | US8846657, 5.3 | US8846657, 5.4 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H37ClN8O3 | ||
Mol. Mass. | 605.13 | ||
SMILES | C[C@H]1CC[C@H](Cn2c(nc3cc(nc(-c4cncc(Cl)c4)c23)-c2noc(=O)[nH]2)N2[C@H](C)CN(C[C@H]2C)C(=O)C2CC2)CC1 |r,wU:4.4,29.33,wD:1.0,34.39,(5.68,-3.69,;4.19,-3.29,;3.8,-1.81,;2.31,-1.41,;1.22,-2.5,;-.27,-2.1,;-.67,-.61,;.24,.64,;-.67,1.88,;-2.13,1.41,;-3.47,2.18,;-4.8,1.41,;-4.8,-.13,;-3.47,-.9,;-3.47,-2.44,;-2.13,-3.21,;-2.13,-4.75,;-3.47,-5.52,;-4.8,-4.75,;-6.13,-5.52,;-4.8,-3.21,;-2.13,-.13,;-6.13,2.18,;-7.6,1.7,;-8.5,2.95,;-7.6,4.19,;-8.37,5.52,;-6.13,3.72,;1.78,.64,;2.55,-.7,;1.21,-1.47,;4.09,-.7,;4.86,.64,;4.09,1.97,;2.55,1.97,;1.78,3.3,;6.4,.64,;7.17,1.97,;7.17,-.7,;7.17,-2.24,;8.5,-1.47,;1.62,-3.98,;3.11,-4.38,)| | ||
Structure |